Abbott Is All Thai'd Up in Kaletra Crisis
Activist protests steal thunder from Abbott's shareholder meeting.
AstraZeneca Serious, 'Not Desperate,' in MedImmune Deal
Pricey merger adds expertise in vaccines, biologics.
